Sinonasal Tumors: Clinical and Morphological Characteristics and Differential Diagnosis
A. I. Prokhorova,
S. I. Samoylova,
O. A. Levendyuk,
M. I. Didenko,
I. V. Reshetov,
N. S. Sukortseva,
O. V. Samoilova,
T. A. Demura https://doi.org/10.35401/2541-9897-2024-9-3-70-78
Abstract
Malignant sinonasal tumors are rare and account for 1% of all neoplasms. Most of these carcinomas are poorly differentiated or undifferentiated tumors. Due to overlapping features, both young and experienced physicians encounter difficulties in their diagnosis. We present 2 cases of 2 tumors of the sinonasal tract, which belong to small round blue cell tumors: sinonasal small cell neuroendocrine tumor and esthesioneuroblastoma.
About the Authors
A. I. Prokhorova
Central Clinical Hospital “Russian Railways-Medicine”
Russian Federation
Russian Federation
Anna I. Prokhorova, Pathologist, Centralized Pathology Center
S. I. Samoylova
I.M. Sechenov First Moscow State Medical University; Central Clinical Hospital “Russian Railways-Medicine”
Russian Federation
Russian Federation
Svetlana I. Samoylova, Cand. Sci. (Med.), Associate Professor at the Department of Oncology, Radiotherapy and Plastic Surgery; Head
of the Centralized Pathology Center, Pathologist
O. A. Levendyuk
Central Clinical Hospital “Russian Railways-Medicine”
Russian Federation
Russian Federation
Olesia A. Levendyuk, Cand. Sci. (Med.), Head of the Laboratory of Immunohistochemical and Molecular Genetic Studies
M. I. Didenko
Central Clinical Hospital “Russian Railways-Medicine”
Russian Federation
Russian Federation
Margarita I. Didenko, Pathologist, Centralized Pathology Center
building 13, ulitsa Budaiskaya 2, Moscow, 129128
I. V. Reshetov
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Igor V. Reshetov, Dr. Sci. (Med.), Academician of the Russian Academy of Sciences, Director of the Scientific and Educational Clinical Center for Plastic Reconstructive Surgery and Oncology, Head of the Department of Oncology, Radiotherapy and Plastic Surgery
N. S. Sukortseva
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Nataliya S. Sukortseva, Oncologist, Oncological Division of Combined Treatment Methods, University Clinical Hospital No. 1, Assistant Professor at the Department of Oncology, Radiotherapy and Plastic Surgery
O. V. Samoilova
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Olga V. Samoilova, Radiologist, Resident, Department of Oncology, Radiotherapy and Plastic Surgery
T. A. Demura
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Tatiana A. Demura, Dr. Sci. (Med.), Director of the Institute of Clinical Morphology and Digital Pathology
References
1. Bracigliano A, Tatangelo F, Perri F, et al. Malignant sinonasal tumors: update on histological and clinical management. Curr Oncol. 2021;28(4):2420–2438. PMID: 34287240. PMCID: PMC8293118. https://doi.org/10.3390/curroncol28040222
2. Trieu V, Aulet RM, Ciolino A, Rimash T. SMARCB1-deficient sinonasal carcinoma: a case report and discussion of the clinical implications. Ann Otol Rhinol Laryngol. 2019;128(7):676–680. PMID: 30873845. https://doi.org/10.1177/0003489419836668
3. Shaverdashvili K, Azimi-Nekoo E, Cohen P, et al. INI1 (SMARCB1)-deficient undifferentiated sinonasal carcinoma: novel paradigm of molecular testing in the diagnosis and management of sinonasal malignancies. Oncologist. 2020;25(9):738–744. PMID: 32337786. PMCID: PMC7485347. https://doi.org/10.1634/theoncologist.2019-0830
4. Parsel SM, Jawad BA, McCoul ED. SMARCB1-deficient sinonasal carcinoma: systematic review and case report. World Neurosurg. 2020;136:305–310. PMID: 32001406. https://doi.org/10.1016/j.wneu.2020.01.130
5. Bell D, Hanna EY, Agaimy A, Weissferdt A. Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience. Virchows Arch. 2015;467(6):649–656. PMID: 26407663. https://doi.org/10.1007/s00428-015-1853-1
6. McHugh KE, Policarpio-Nicolas MLC. Metastatic SMARCB1 (INI-1)-deficient sinonasal carcinoma diagnosed by endobronchial ultrasound-guided fine-needle aspiration (EBUSFNA): a potential diagnostic pitfall and review of the literature. Acta Cytol. 2019;63(5):431–437. PMID: 31132763. https://doi.org/10.1159/000500351
7. Simons SA, Bridge JA, Leon ME. Sinonasal small round blue cell tumors: an approach to diagnosis. Semin Diagn Pathol. 2016;33(2):91–103. PMID: 26585346. https://doi.org/10.1053/j.semdp.2015.09.010
8. Thompson LD. Small round blue cell tumors of the sinonasal tract: a differential diagnosis approach. Mod Pathol. 2017;30(s1):S1–S26. PMID: 28060373. https://doi.org/10.1038/modpathol.2016.119
9. Bell D. Sinonasal neuroendocrine neoplasms: current challenges and advances in diagnosis and treatment, with a focus on olfactory neuroblastoma. Head Neck Pathol. 2018;12(1):22–30. PMID: 29427030. PMCID: PMC5873495. https://doi.org/10.1007/s12105-018-0887-5
10. WHO Classification of Tumours Editorial Board, ed. Head and Neck Tumours. 5th ed. World Health Organization; 2024. WHO Classification of Tumours; vol 9.
11. Su SY, Bell D, Hanna EY. Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment. Int Arch Otorhinolaryngol. 2014;18(Suppl 2):S149–S156. PMID: 25992139. PMCID: PMC4399581. https://doi.org/10.1055/s-0034-1390014
12. Han G, Wang Z, Guo X, Wang M, Wu H, Liu D. Extrapulmonary small cell neuroendocrine carcinoma of the paranasal sinuses: a case report and review of the literature. J Oral Maxillofac Surg. 2012;70(10):2347–2351. PMID: 22330330. https://doi.org/10.1016/j.joms.2011.10.034
13. Raychowdhuri RN. Oat-cell carcinoma and paranasal sinuses. J Laryngol Otol. 1965;79:253–255. PMID: 14270662. https://doi.org/10.1017/s0022215100063660
14. Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol. 2002;15(3):264–278. PMID: 11904342. https://doi.org/10.1038/modpathol.3880522
15. Mittal R, Kaza H, Agarwal S, Rath S, Gowrishankar S. Small cell neuroendocrine carcinoma of the orbit presenting as an orbital abscess in a young female. Saudi J Ophthalmol. 2019;33(3):308–311. PMID: 31686977. PMCID: PMC6819753. https://doi.org/10.1016/j.sjopt.2018.07.003
16. Rivero A, Liang J. Sinonasal small cell neuroendocrine carcinoma: a systematic review of 80 patients. Int Forum Allergy Rhinol. 2016;6(7):744–751. PMID: 26880574. https://doi.org/10.1002/alr.21734
17. Bishop JA, Guo TW, Smith DF, et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol. 2013;37(2):185–192. PMID: 23095507. PMCID: PMC3545097. https://doi.org/10.1097/PAS.0b013e3182698673
18. Laco J, Sieglová K, Vošmiková H, et al. The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis. Virchows Arch. 2015;467(4):405–415. PMID: 26229021. https://doi.org/10.1007/s00428-015-1812-x
19. Wang CP, Hsieh CY, Chang YL, et al. Postirradiated neuroendocrine carcinoma of the sinonasal tract. Laryngoscope. 2008;118(5):804–809. PMID: 18520182. https://doi.org/10.1097/MLG.0b013e3181671491
20. Chapurin N, Totten DJ, Louis PC, et al. Sinonasal small cell carcinoma-case series of a rare malignancy. Ear Nose Throat J. 2022;101(6):392–395. PMID: 33090899. https://doi.org/10.1177/0145561320964640
21. Babin E, Rouleau V, Vedrine PO, et al. Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. J Laryngol Otol. 2006;120(4):289–297. PMID: 16526967. https://doi.org/10.1017/S0022215106000594
22. Dearnaley D. Small-cell lung cancer: report of a meeting of physicians and scientists at the Royal Marsden Hospital. Lancet. 1995;345:1285–1289.
23. Ibrahim NB, Briggs JC, Corbishley CM. Extrapulmonary oat cell carcinoma. Cancer. 1984;54(8):1645–1661. PMID: 6089995.
24. Iezzoni JC, Mills SE. “Undifferentiated” small round cell tumors of the sinonasal tract: differential diagnosis update. Am J Clin Pathol. 2005;124 Suppl:S110–S121. PMID: 16468421. https://doi.org/10.1309/59RBT2RK6LQE4YHB
25. Dzagakhova AV, Katamadze NN, Pigarova EA. Syndrome of inappropriate secretion of antidiuretic hormone in the practice of endocrinologist. Endocrine Surgery. 2020;14(3):4–12. (In Russ.). https://doi.org/10.14341/serg12692
26. Thompson LDR. Olfactory neuroblastoma. In: Thompson LDR, Müller S, Nelson BL. Diagnostic Pathology: Head and Neck. 3rd ed. Elsevier; 2022:154–164.
27. Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res. 1997;17(4A):2683–2706. PMID: 9252701.
28. Klepin HD, McMullen KP, Lesser GJ. Esthesioneuroblastoma. Curr Treat Options Oncol. 2005;6(6):509–518. PMID: 16242055. https://doi.org/10.1007/s11864-005-0029-7
29. Kumar R. Esthesioneuroblastoma: multimodal management and review of literature. World J Clin Cases. 2015;3(9):774– 778. PMID: 26380824. PMCID: PMC4568526. https://doi.org/10.12998/wjcc.v3.i9.774
30. Gray ST, Holbrook EH, Najm MH, Sadow PM, Curry WT, Lin DT. Syndrome of inappropriate antidiuretic hormone secretion in patients with olfactory neuroblastoma. Otolaryngol Head Neck Surg. 2012;147(1):147–151. PMID: 22368044. https://doi.org/10.1177/0194599812438842
31. Holland H, Koschny R, Krupp W, et al. Comprehensive cytogenetic characterization of an esthesioneuroblastoma. Cancer Genet Cytogenet. 2007;173(2):89–96. PMID: 17321323. https://doi.org/10.1016/j.cancergencyto.2006.09.024
32. Bockmühl U, You X, Pacyna-Gengelbach M, Arps H, Draf W, Petersen I. CGH pattern of esthesioneuroblastoma and their metastases. Brain Pathol. 2004;14(2):158–163. PMID: 15193028. PMCID: PMC8095953. https://doi.org/10.1111/j.1750-3639.2004.tb00048.x
33. Nair SS, Elizabeth MI. Esthesioneuroblastoma. Indian J Otolaryngol Head Neck Surg. 1998;50(1):33–35. PMID: 23119374. PMCID: PMC3451258. https://doi.org/10.1007/BF02996765
34. Gorbunova TV, Rodina AD, Shishkov RV, et al. Approaches to the treatment of children with esthesioneuroblastoma: literature review. Oncopediatrics. 2019;6(2):78–86. (In Russ.). https://doi.org/10.15690/onco.v6i2.2019
35. Mustafaev DM, Svistushkin VM, Sambulov VI, et al. Esthesioneroblastoma of the nasal cavity (olfactory neuroblastoma). Rossiiskaya otorinolaringologiya. 2009;(5):85–91. (In Russ.).
36. PachesAI. Head and Neck Tumors. Meditsina; 1983. (In Russ.).
37. Ghaffar S, Salahuddin I. Olfactory neuroblastoma: a case report and review of the literature. Ear Nose Throat J. 2005;84(3):150– 152. PMID: 15871582.
38. Kumar R, Ghoshal S, Khosla D, et al. Survival and failure outcomes in locally advanced esthesioneuroblastoma: a single centre experience of 15 patients. Eur Arch Otorhinolaryngol. 2013;270(6):1897–1901. PMID: 23179939. https://doi.org/10.1007/s00405-012-2280-4
Review
For citations:
Prokhorova A.I., Samoylova S.I., Levendyuk O.A., Didenko M.I., Reshetov I.V., Sukortseva N.S., Samoilova O.V., Demura T.A. Sinonasal Tumors: Clinical and Morphological Characteristics and Differential Diagnosis. Innovative Medicine of Kuban. 2024;(3):70-78. (In Russ.) https://doi.org/10.35401/2541-9897-2024-9-3-70-78
Views:
392
Email this article 
